The "Begin Exploring Fertility Options, Risks and Expectations" (BEFORE) decision aid: development and alpha testing of a fertility tool for premenopausal breast cancer patients

Brittany Speller, Kelly Metcalfe, Erin D Kennedy, Marcia Facey, Ellen Greenblatt, Adena S Scheer, Ellen Warner, Anil Abraham Joy, Frances C Wright, Nancy N Baxter, Brittany Speller, Kelly Metcalfe, Erin D Kennedy, Marcia Facey, Ellen Greenblatt, Adena S Scheer, Ellen Warner, Anil Abraham Joy, Frances C Wright, Nancy N Baxter

Abstract

Background: Premenopausal breast cancer patients are at risk of treatment-related infertility. Many patients do not receive sufficient fertility information before treatment. As such, our team developed and alpha tested the Begin Exploring Fertility Options, Risks, and Expectations decision aid (BEFORE DA).

Methods: The BEFORE DA development process was guided by the International Patient Decision Aids Standards and the Ottawa Decision Support Framework. Our team used integrated knowledge translation by collaborating with multiple stakeholders throughout the development process including breast cancer survivors, multi-disciplinary health care providers (HCPs), advocates, and cancer organization representatives. Based on previously conducted literature reviews and a needs assessment by our team - we developed a paper prototype. The paper prototype was finalized at an engagement meeting with stakeholders and created into a graphically designed paper and mirrored online decision aid. Alpha testing was conducted with new and previously engaged stakeholders through a questionnaire, telephone interviews, or focus group. Iterative reviews followed each step in the development process to ensure a wide range of stakeholder input.

Results: Our team developed an 18-page paper prototype containing information deemed valuable by stakeholders for fertility decision-making. The engagement meeting brought together 28 stakeholders to finalize the prototype. Alpha testing of the paper and online BEFORE DA occurred with 17 participants. Participants found the BEFORE DA usable, acceptable, and most provided enthusiastic support for its use with premenopausal breast cancer patients facing a fertility decision. Participants also identified areas for improvement including clarifying content/messages and modifying the design/photos. The final BEFORE DA is a 32-page paper and mirrored online decision aid ( https://fertilityaid.rethinkbreastcancer.com ). The BEFORE DA includes information on fertility, fertility options before/after treatment, values clarification, question list, next steps, glossary and reference list, and tailored information on the cost of fertility preservation and additional resources by geographic location.

Conclusion: The BEFORE DA, designed in collaboration with stakeholders, is a new tool for premenopausal breast cancer patients and HCPs to assist with fertility discussions and decision-making. The BEFORE DA helps to fill the information gap as it is a tool that HCPs can refer patients to for supplementary information surrounding fertility.

Keywords: Alpha testing; Breast cancer; Decision aid; Decision-making; Fertility preservation; Oncofertility.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
BEFORE (Begin Exploring Fertility Options, Risks, and Expectations) decision aid development process
Fig. 2
Fig. 2
Recruitment strategy for alpha testing participants

References

    1. Peate M, Meiser B, Hickey M, Friedlander M. The fertility-related concerns, needs and preferences of younger women with breast cancer: a systematic review. Breast Cancer Res Treat. 2009;116:215. doi: 10.1007/s10549-009-0401-6.
    1. Oktay K, Harvey BE, Partridge AH, Quinn GP, Reinecke J, Taylor HS, et al. Fertility preservation in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2018;36:1994–2001. doi: 10.1200/JCO.2018.78.1914.
    1. Burstein HJ, Temin S, Anderson H, Buchholz TA, Davidson NE, Gelmon KE, et al. Adjuvant endocrine therapy for women with hormone receptor–positive breast cancer: American Society of Clinical Oncology clinical practice guideline focused update. J Clin Oncol. 2014;32:2255–2269. doi: 10.1200/JCO.2013.54.2258.
    1. Woodruff TK. Oncofertility: a grand collaboration between reproductive medicine and oncology. Reproduction. 2015;150:S1–10. doi: 10.1530/REP-15-0163.
    1. Ronn R, Holzer HEG. Oncofertility in Canada: an overview of Canadian practice and suggested action plan. Curr Oncol. 2013;20:e465–ee74. doi: 10.3747/co.20.1361.
    1. Rethink Breast Cancer. Breast cancer in young women in Canada - a needs assessment. 2015. . Accessed 5 January 2017.
    1. Stacey D, Légaré F, Col NF, Bennett CL, Barry MJ, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2014, Issue 1. Art. No.: CD001431. 10.1002/14651858.pub4.
    1. Stacey D, Légaré F, Lewis K, Barry MJ, Bennett CL, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2017, Issue 4. Art. No.:CD001431. 10.1002/14651858.pub5.
    1. Thewes B, Meiser B, Taylor A, Phillips KA, Pendlebury S, Capp A, et al. Fertility- and menopause-related information needs of younger women with a diagnosis of early breast Cancer. J Clin Oncol. 2005;23:5155–65.
    1. Baysal Ö, Bastings L, Beerendonk C, Postma S, IntHout J, Verhaak C, et al. Decision-making in female fertility preservation is balancing the expected burden of fertility preservation treatment and the wish to conceive. Hum Reprod. 2015;30:1625–1634. doi: 10.1093/humrep/dev116.
    1. Ehrbar V, Urech C, Alder J, Harringer K, Dällenbach RZ, Rochlitz C, et al. Decision-making about fertility preservation—qualitative data on young cancer patients’ attitudes and needs. Arch Womens Ment Health. 2016;19:695–699. doi: 10.1007/s00737-016-0604-x.
    1. Quinn GP, Vadaparampil ST, Sehovic I, Clayman ML. Patient and family tools to aid in education and decision-making about oncofertility. Oncofertility Communication. New York: Springer; 2014. pp. 35–47.
    1. Peate M, Meiser B, Friedlander M, Saunders C, Martinello R, Wakefield CE, et al. Development and pilot testing of a fertility decision aid for young women diagnosed with early breast cancer. Breast. 2011;17:112–114. doi: 10.1111/j.1524-4741.2010.01033.x.
    1. Garvelink MM, ter Kuile MM, Fischer MJ, Louwé LA, Hilders CGJM, Kroep JR, et al. Development of a decision aid about fertility preservation for women with breast cancer in the Netherlands. J Psychosom Obstet Gynecol. 2013;34:170–178. doi: 10.3109/0167482X.2013.851663.
    1. Ehrbar V, Urech C, Rochlitz C, Dällenbach RZ, Moffat R, Stiller R, et al. Fertility preservation in young female cancer patients: development and pilot testing of an online decision aid. J Adolesc Young Adult Oncol. 2018;7:30–36. doi: 10.1089/jayao.2017.0047.
    1. Woodard TL, Hoffman AS, Crocker LC, Holman DA, Hoffman DB, Ma J, et al. Pathways: patient-centred decision counselling for women at risk of cancer-related infertility: a protocol for a comparative effectiveness cluster randomised trial. BMJ Open. 2018;8:e019994. doi: 10.1136/bmjopen-2017-019994.
    1. Jones G, Hughes J, Mahmoodi N, Greenfield D, Brauten-Smith G, Skull J, et al. Observational study of the development and evaluation of a fertility preservation patient decision aid for teenage and adult women diagnosed with cancer: the Cancer. Fertility and Me research protocol. BMJ Open. 2017;7:e013219.
    1. Coulter A, Stilwell D, Kryworuchko J, Mullen PD, Ng CJ, van der Weijden T. A systematic development process for patient decision aids. BMC Med Inform Decis Mak. 2013;13:S2. doi: 10.1186/1472-6947-13-S2-S2.
    1. O'Connor A, Stacey D, Boland L. Ottawa decision support tutorial. 2015.
    1. Volk RJ, Llewellyn-Thomas H, Stacey D, Elwyn G. Ten years of the International Patient Decision Aid Standards Collaboration: evolution of the core dimensions for assessing the quality of patient decision aids. BMC Med Inform Decis Mak. 2013;13:S1.
    1. Elwyn G, O'Connor A, Stacey D, Volk R, Edwards A, Coulter A, et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ. 2006;333:417. doi: 10.1136/.
    1. O’Connor AM. Ottawa decision support framework to address decisional conflict. 2006.
    1. Graham ID, Tetroe J, Pearson A. Turning knowledge into action: practical guidance on how to do integrated knowledge translation research: Lippincott Williams & Wilkins. 2014.
    1. Daly C, Micic S, Facey M, Speller B, Yee S, Kennedy ED, et al. A review of factors affecting patient fertility preservation discussions & decision-making from the perspectives of patients and providers. Eur J Cancer Care. 2018; 28(1):e12945.
    1. Speller B, Micic S, Daly C, Pi L, Little T, Baxter NN. Oncofertility decision support resources for women of reproductive age: systematic review. JMIR Cancer. 2019;5:e12593.
    1. Covelli A, Facey M, Daly C, Kennedy E, Baxter Nancy N. "The Inertia of Practice": Challenges in addressing infertility in young women with cancer. J Clin Oncol. 2016; 34, (no. 15_suppl):10079-10079.
    1. Speller B, Sissons A, Daly C, Facey M, Kennedy E, Metcalfe K, et al. An evaluation of oncofertility decision support resources among breast cancer patients and health care providers. BMC Health Serv Res. 2019;19:101. doi: 10.1186/s12913-019-3901-z.
    1. Fagerlin A, Pignone M, Abhyankar P, Col N, Feldman-Stewart D, Gavaruzzi T, et al. Clarifying values: an updated review. BMC Med Inform Decis Mak. 2013;13:S8. doi: 10.1186/1472-6947-13-S2-S8.
    1. Metcalfe K, Poll A, O’connor A, Gershman S, Armel S, Finch A, et al. Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation. Clin Genet. 2007;72:208–217. doi: 10.1111/j.1399-0004.2007.00859.x.
    1. Fortnum D, Smolonogov T, Walker R, Kairaitis L, Pugh D. ‘My kidneys, my choice, decision aid’: supporting shared decision making. J Ren Care. 2015;41:81–87. doi: 10.1111/jorc.12100.
    1. Trevena LJ, Zikmund-Fisher BJ, Edwards A, Gaissmaier W, Galesic M, Han PK, et al. Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers. BMC Med Inform Decis Mak. 2013;13:S7. doi: 10.1186/1472-6947-13-S2-S7.
    1. Azim HA, Santoro L, Pavlidis N, Gelber S, Kroman N, Azim H, et al. Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. Eur J Cancer. 2011;47:74–83. doi: 10.1016/j.ejca.2010.09.007.
    1. Azim HA, Jr, Kroman N, Paesmans M, Gelber S, Rotmensz N, Ameye L, et al. Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study. J Clin Oncol. 2012;31:73–79. doi: 10.1200/JCO.2012.44.2285.
    1. Cardonick EH. Overview of infertility and pregnancy outcome in cancer survivors. 2018.
    1. Lambertini M, Del Mastro L, Pescio MC, Andersen CY, Azim HA, Peccatori FA, et al. Cancer and fertility preservation: international recommendations from an expert meeting. BMC Med. 2016;14.
    1. Dalberg K, Eriksson J, Holmberg L. Birth outcome in women with previously treated breast cancer—a population-based cohort study from Sweden. PLoS Med. 2006;3:e336. doi: 10.1371/journal.pmed.0030336.
    1. Fritz MA, Speroff L. Clinical gynecologic endocrinology and infertility. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2011.
    1. Partridge AH, Ruddy KJ. Fertility and adjuvant treatment in young women with breast cancer. Breast. 2007;16:175–181. doi: 10.1016/j.breast.2007.07.029.
    1. Canadian Assisted Reproductive Technologies Registry (CARTR) Plus . Final treatment cycle and pregnancy outcome data for 2014. Ottawa ON: Better Outcomes Registry & Network Ontario; 2016.
    1. Cil AP, Bang H, Oktay K. Age-specific probability of live birth with oocyte cryopreservation: an individual patient data meta-analysis. Fertil Steril. 2013;100:492–499. doi: 10.1016/j.fertnstert.2013.04.023.
    1. Corbett S, Shmorgun D, Claman P, Cheung A, Sierra S, Carranza-Mamane B, et al. The prevention of ovarian hyperstimulation syndrome. J Obstet Gynaecol Can. 2014;36:1024–1033. doi: 10.1016/S1701-2163(15)30417-5.
    1. Lambertini M, Ceppi M, Poggio F, Peccatori FA, Azim H, Ugolini D, et al. Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies. Ann Oncol. 2015;26:2408–2419. doi: 10.1093/annonc/mdv335.01.
    1. Duffy C, Allen S. Medical and psychosocial aspects of fertility after cancer. Cancer J. 2009;15:27–33. doi: 10.1097/PPO.0b013e3181976602.
    1. Logan S, Perz J, Ussher JM, Peate M, Anazodo A. Systematic review of fertility-related psychological distress in cancer patients: informing on an improved model of care. Psycho-oncology. 2019;28:22–30. doi: 10.1002/pon.4927.
    1. Canadian Cancer Society. . Accessed 31 October 2016.
    1. Fertile Future. . Accessed 31 October 2016.
    1. American Society for Reproductive Medicine. . Accessed 31 October 2016.
    1. . . Accessed 31 October 2016.
    1. Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24:2917–2931. doi: 10.1200/JCO.2006.06.5888.
    1. Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, et al. Fertility preservation for patients with Cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31:2500–10.
    1. Patton MQ. Qualitative research & evaluation methods. 3. Thousand Oaks: Sage Publications, Inc.; 2002.
    1. SurveyMonkey LLC. SurveyMonkey®. 2012.
    1. James S, Eggers M, Hughes-Rease M, Loup R, Seiford B. In: Facilitating large group meetings that get results every time. Schuman S, editor. San Francisco: The IAF Handbook of Group Facilitation; 2005. pp. 335–350.
    1. OfftoMarket Inc. . Accessed 16 November 2018.
    1. Smith S. SAM—suitability assessment of materials for evaluation of health-related information for adults. 2008.
    1. Flesch R. A new readability yardstick. J Appl Psychol. 1948;32:221–233. doi: 10.1037/h0057532.
    1. Doak CC, Doak LG, Root JH. Teaching patients with low literacy skills. 2. Philadelphia, PA: Lippincott; 1996.
    1. . . Accessed 28 Aug 2017.
    1. McCaffery KJ, Holmes-Rovner M, Smith SK, Rovner D, Nutbeam D, Clayman ML, et al. Addressing health literacy in patient decision aids. BMC Med Inform Decis Mak. 2013;13:S10. doi: 10.1186/1472-6947-13-S2-S10.
    1. Joseph-Williams N, Newcombe R, Politi M, Durand M-A, Sivell S, Stacey D, et al. Toward minimum standards for certifying patient decision aids a modified delphi consensus process. Med Decis Mak. 2013;34:699–710. doi: 10.1177/0272989X13501721.
    1. Faulkner L. Beyond the five-user assumption: benefits of increased sample sizes in usability testing. Behav Res Methods. 2003;35:379–383. doi: 10.3758/BF03195514.
    1. O’Connor A, Cranney A. User manual – acceptability. 1996.
    1. Lau YK, Caverly TJ, Cherng ST, Cao P, West M, Arenberg D, et al. Development and validation of a personalized, web-based decision aid for lung cancer screening using mixed methods: a study protocol. JMIR Res Protoc. 2014;3:e78. doi: 10.2196/resprot.4039.
    1. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101. doi: 10.1191/1478088706qp063oa.
    1. American Society for Reproductive Medicine . Age and fertility. 2012.
    1. American Society of Reproductive Medicine . In vitro fertilization (IVF): what are the risks? 2015.
    1. McGill University Health Centre. In vitro maturation (IVM). . Accessed 30 August 2016.
    1. Human Fertilization & Embryo Authority . What is in vitro maturation (IVM) and how does it work? 2015.
    1. Baxter N, Kennedy E, Wright F, Brezden-Masley C, Simmons C. Gupta A, et al. BEFORE – Begin Exploring Fertility Options, Risks & Expectations. 2017. . Accessed 28 Aug 2018.
    1. Transperfect. Translation. . Accessed June 17 2019.
    1. Web Content Accessibility Guidelines (WCAG) overview. 2005 [updated 2018]. https://. Accessed 4 April 2017.
    1. Rethink Breast Cancer . Care guidelines for young women with breast cancer. 2015.
    1. Scalia P, Elwyn G, Durand M-A. "provoking conversations": case studies of organizations where option grid™ decision aids have become 'normalized'. BMC Med Inform Decis Mak. 2017;17:124. doi: 10.1186/s12911-017-0517-2.
    1. Women’s College Research Institute . SPOKE (surgeon and patient Oncofertility knowledge enhancement) physician and patient option grids. 2015.
    1. Quinn GP, Vadaparampil ST, Gwede CK, Miree C, King LM, Clayton HB, et al. Discussion of fertility preservation with newly diagnosed patients: oncologists’ views. J Cancer Surviv. 2007;1:146–155. doi: 10.1007/s11764-007-0019-9.
    1. Forman EJ, Anders CK, Behera MA. A nationwide survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients. Fertil Steril. 2010;94:1652–1656. doi: 10.1016/j.fertnstert.2009.10.008.
    1. Snyder K, Pearse W. Discussing fertility preservation options with patients with cancer. JAMA. 2011;306:202–203. doi: 10.1001/jama.2011.973.
    1. Hand M, Kemertzis MA, Peate M, Gillam L, McCarthy M, Orme L, et al. A clinical decision support system to assist pediatric oncofertility: a short report. J Adolesc Young Adult Oncol. 2018;7:509–513. doi: 10.1089/jayao.2018.0006.
    1. Mathur A. Role of spouse/partner in fertility preservation decision making by young women with Cancer: Portland State University. 2018.
    1. Hershberger PE, Finnegan L, Pierce PF, Scoccia B. The decision-making process of young adult women with cancer who considered fertility cryopreservation. J Obstet Gynecol Neonatal Nurs. 2013;42:59–69. doi: 10.1111/j.1552-6909.2012.01426.x.
    1. Feldman-Stewart D, O’Brien MA, Clayman ML, Davison BJ, Jimbo M, Labrecque M, et al. Providing information about options in patient decision aids. BMC Med Inform Decis Mak. 2013;13:S4. doi: 10.1186/1472-6947-13-S2-S4.
    1. Atkinson T. Plain language and patient education: a summary of current research: Centre for literacy. 2003.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj